openPR Logo
Press release

Increasing Cancer Epidemic Driving Growth In The Oligonucleotide Therapy Market: The Driving Engine Behind Oligonucleotide Therapy Market Evolution in 2025

09-15-2025 08:30 AM CET | Health & Medicine

Press release from: The Business Research Company

Oligonucleotide Therapy

Oligonucleotide Therapy

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Oligonucleotide Therapy Market Size Growth Forecast: What to Expect by 2025?
The market size for oligonucleotide therapy has been swiftly expanding in the past few years. Projected growth is from $5.61 billion in 2024 to $6.2 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. The increase during the historic phase could be linked to increased investment in research and development, the emergence of initial therapies, the ascendance of gene editing techniques, early treatment discoveries and the introduction of RNAi and antisense oligonucleotide.

How Will the Oligonucleotide Therapy Market Size Evolve and Grow by 2029?
In the years to come, the oligonucleotide therapy market is projected to experience swift expansion. The market size is predicted to reach "$9.66 billion in 2029 with a compound annual growth rate (CAGR) of 11.8%. The anticipated growth in this period is credited to investment in research and development, increased global market penetration, expansion of the therapeutic area, implementation of disease modification strategies, and regulatory adaptations. Key trends projected throughout this period include the development of personalized therapies, advancements in delivery systems, the progression of RNA interference (RNAI), innovation in antisense oligonucleotide, as well as the incorporation of gene editing techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

What Drivers Are Propelling the Growth of Oligonucleotide Therapy Market Forward?
The escalating incidences of cancer worldwide is anticipated to bolster the expansion of the oligonucleotide therapy market in the forecast period. For example, the American Cancer Society speculated in January 2022 that the US is likely to observe 1.9 million fresh cancer diagnoses and 609,360 deaths linked to cancer, roughly 1,670 casualties daily. The four most prevalent cancer types globally - lung, prostate, bowel, and female breast cancer - represent 43% of all new cancer diagnoses. Hence, the increasing rate of cancer globally predicts an upswing in demand for oligonucleotide therapy in the ensuing years.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

What Are the Key Trends Driving Oligonucleotide Therapy Market Growth?
The market entities involved in the oligonucleotide therapy arena are channelling their resources into research and development to modify the therapy design and decrease its negative impact on patients. The cutting-edge oligonucleotides open avenues for precision medicine methodologies and can be engineered to selectively interact with any gene while causing minimal side-effects. It is also beneficial in zeroing in on specific sequences in patients that lead to rare diseases. In April 2023, Qalsody, an antisense oligonucleotide (ASO), gained FDA approval for usage in treating patients affected with amyotrophic lateral sclerosis (ALS) related to a mutation in the superoxide dismutase 1 (SOD1) gene. SOD1 mRNA is the target of Qalsody to curb the SOD1 protein synthesis.

What Are the Key Segments in the Oligonucleotide Therapy Market?
The oligonucleotide therapy market covered in this report is segmented -

1) By Type: Antisense Oligonucleotide, Aptamer, Other Types
2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User
3) By End User: Hospitals, Research Institutes

Subsegments:
1) By Antisense Oligonucleotide: RNA-Targeted Antisense Oligonucleotides, DNA-Targeted Antisense Oligonucleotides, Chemically Modified Antisense Oligonucleotides
2) By Aptamer: DNA Aptamers, RNA Aptamers, Small Molecule Aptamers
3) By Other Types: siRNA (Small Interfering RNA), miRNA (Micro RNA), DNAzyme And Ribozymes, Synthetic Oligonucleotides For Gene Editing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3398&type=smp

Who Are the Key Players Shaping the Oligonucleotide Therapy Market's Competitive Landscape?
Major companies operating in the oligonucleotide therapy market include Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Gilead Sciences Inc., BioNTech SE, Moderna Inc., Biogen Inc., Jazz Pharmaceuticals plc, QIAGEN Company, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Ionis Pharmaceuticals Inc., Akcea Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., SomaGenics Inc., Wave Life Sciences Ltd., Exicure Inc., Avidity Biosciences Inc., Miragen Therapeutics Inc., ProQR Therapeutics NV, Regulus Therapeutics Inc., Kastle Therapeutics LLC, Santaris Pharma A/S, InteRNA Technologies B.V., Dynacure S.A., Arcturus Therapeutics Holdings Inc., Intellia Therapeutics Inc., Regeneron Pharmaceuticals Inc., Editas Medicine Inc., Evox Therapeutics Ltd., PepGen Ltd.

What Geographic Markets Are Powering Growth in the Oligonucleotide Therapy Market?
North America was the largest region in the oligonucleotide therapy market in 2024. The regions covered in the oligonucleotide therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3398

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email:saumyas@tbrc.info
The Business Research Company -www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increasing Cancer Epidemic Driving Growth In The Oligonucleotide Therapy Market: The Driving Engine Behind Oligonucleotide Therapy Market Evolution in 2025 here

News-ID: 4182161 • Views:

More Releases from The Business Research Company

Key Trends Reshaping the Agricultural Biotechnology Market: Innovative Biotechnologies Transforming Agriculture Focus On Integrated Solutions Industry Transformation
Key Trends Reshaping the Agricultural Biotechnology Market: Innovative Biotechno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Agricultural Biotechnology Market Size Growth Forecast: What to Expect by 2025? In recent times, the agricultural biotechnology market has witnessed considerable growth. It is anticipated to expand from $44.82 billion in 2024 to $49.18 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 9.7%. This significant increase
Health-Conscious Trends Propel Growth In Sorghum Seed Market: Transformative Forces Shaping the Sorghum Seed Market Landscape in 2025
Health-Conscious Trends Propel Growth In Sorghum Seed Market: Transformative For …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Sorghum Seed Industry Market Size Be by 2025? Over recent years, the sorghum seed market has experienced a significant uptick in growth. The market is projected to escalate from a value of $2.06 billion in 2024 to $2.18 billion in 2025, advancing at a compound annual
Steady Expansion Forecast for Meat Market, Projected to Reach $1599.32 Billion by 2029
Steady Expansion Forecast for Meat Market, Projected to Reach $1599.32 Billion b …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Meat Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The expansion of the meat market has been robust in the last few years. The market which is projected to be at $1133.29 billion in 2024 is expected to escalate to $1217.95 billion in 2025 with
Grain Farming Industry Outlook 2025-2029: Market Set to Cross $1633.78 Billion Milestone
Grain Farming Industry Outlook 2025-2029: Market Set to Cross $1633.78 Billion M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Grain Farming Market Size By 2025? In the past few years, the size of the grain farming market has significantly expanded. It is projected to rise from $1139.2 billion in 2024 to $1226.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%.

All 5 Releases


More Releases for Oligonucleotide

Oligonucleotide Synthesis Market CAGR 9.9% by 2035, Due To The Growing Demand Fo …
According to our latest market report "Oligonucleotide Synthesis Market by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-users, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the global oligonucleotide synthesis market size is projected to reach USD 13.5 billion by 2035 from USD 4.8 billion in 2024, growing at a CAGR of 9.9% in the forecast period
Oligonucleotide Synthesis Market Outlook, 2030
The global oligonucleotide synthesis market is set to witness unprecedented growth in the coming decade, driven by advancements in biotechnology, increasing applications in genetic research, and rising demand for personalized medicine. According to market research, the global oligonucleotide synthesis market size was valued at USD 5.198 billion in 2020 and is projected to reach USD 26.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.10% from
Antisense Oligonucleotide Therapeutics Market
Antisense Oligonucleotide Therapeutics Market worth $ 64.64 Billion by 2030 - Exclusive Report by Insight Analytics Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Antisense Oligonucleotide Therapeutics Market- by Therapy (Monotherapy and Combination), Molecule Target Indication (DNA Molecule and RNA Molecule), Target Indication (Duchenne Muscular Atrophy, Spinal Muscular Atrophy, Familial Chylomicronemia Syndrome, Amyotrophic Lateral Sclerosis, Familial Partial Lipodystrophy, Hereditary Transthyretin-Mediated (hatter) Amyloidosis, Huntington's Disease
Oligonucleotide Therapy Market Transforming Healthcare: The Oligonucleotide Ther …
Oligonucleotide Therapy Market worth $19.92 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oligonucleotide Therapy Market - (By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User (Hospitals, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According
Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthes …
Researchmoz added latest report "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis
Oligonucleotide Synthesis Market 2017 Development Trends
This report studies the global Oligonucleotide Synthesis market, analyzes and researches the Oligonucleotide Synthesis development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Agilent Technologies Biosearch Technologies Eurofins Genomics Eurogentec Integrated DNA Technologies Merck KGAA Thermo Fisher Scientific GeneDesign Bio-Synthesis - CRO/CMO Life Sciences Company Bioautomation GE Healthcare LGC Biosearch Technologies NITTO Denko Avecia For more information about this report at http://www.reportsweb.com/global-oligonucleotide-synthesis-market-size-status-and-forecast-2022 Market segment by Regions/Countries, this report